Dr. David Molthrop
Hematology/oncology
Florida, United States
About Dr. Molthrop
Dr. Molthrop is an Hematology/oncology Specialist in Orlando, Florida. He graduated from Louisiana State University School Of Medicine In New Orleans in 1987. Dr. Molthrop accepts Medicare approved amount as full payment.
The medical group (Florida Ca) Dr. Molthrop works with accepts Medicare approved amount as full payment.
Full Name
David Molthrop
Specialty
Hematology/oncology
School
Louisiana State University School Of Medicine In New Orleans
Graduated class of
1987
Locations
NPI
1194783027
PAC ID
2147483647
Clinician Enrollment ID
I20101029000342
Cities
1
Number of cities where Dr. Molthrop has officesOffices
1
Number of officesHospitals
2
Number of hospitalsOffice Locations
ORLANDO Office
Phone: (407) 898-5452
2501 N Orange Ave
Suite 381
Orlando, FL - 32804-4623
Hospitals
ADVENTHEALTH ORLANDO
CMS Certification Number: 100007
ADVENTHEALTH WATERMAN
CMS Certification Number: 100057
Doctors and Clinicians Utilization Data
Specialty | HCPCS code | Code description | Service Count | Beneficiary count |
---|---|---|---|---|
Hematology/oncology | 36415 | Insertion of needle into vein for collection of blood sample | 2528 | 885 |
Hematology/oncology | 80053 | Blood test, comprehensive group of blood chemicals | 1925 | 786 |
Hematology/oncology | 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 2714 | 907 |
Hematology/oncology | 96366 | Infusion into a vein for therapy, prevention, or diagnosis | 41 | 14 |
Hematology/oncology | 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 455 | 117 |
Hematology/oncology | 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 123 | 45 |
Hematology/oncology | 96413 | Infusion of chemotherapy into a vein up to 1 hour | 273 | 86 |
Hematology/oncology | G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation | 703 | 136 |
Hematology/oncology | J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1702 | 43 |
Questions & Answers
Help others like you find out more about . Do you know the answers to any of these questions? Contribute now and help others like you.
0 Responses